risks of taking tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Phentermine vs tirzepatide: the complete

Compounded products are not FDA-approved and are not interchangeable with brand-name tirzepatide, but the active peptide behaves the same way once injected

GLP-1 receptor agonists caused dose-dependent thyroid C-cell tumors in rodent studies

We provide a personalized framework that addresses the nutritional gaps often created by reduced caloric intake

Rotating sites weekly prevents this complication and ensures consistent drug delivery for steady weight loss results

Authors Lucas Oliveira, Nutritionist, ProVeg International Anna-Lena Klapp, Head of Research, ProVeg International We would like to thank the following people for sharing their time, expertise, and thoughtful review of the brochure: Valentina Gallani, Health & Nutrition Manager, ProVeg International Veronika Mlynrik Baov, Senior Nutrition Specialist, ProVeg Czech Republic Laura Weinhold, Dietitian & Food Services Specialist, ProVeg Germany Stefany Guerreiro Lima, Food and Nutrition Project Manager, ProVeg Brasil Frequently asked questions What should I eat while on GLP-1 medication

Cardiovascular outcomes of liraglutide in patients with type 2 diabetes and ischemic heart disease: A pre-specified subanalysis of the LEADER trial